Sugi Predict

Sugi Predict / Compounds / SCHEMBL10194954

SCHEMBL10194954

SCHEMBL10194954

O=C(c1ccc(-n2cc(-c3n[nH]c4ccccc34)nn2)c(F)c1)N1CCOCC1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ FLT3 P36888 4/20 0.50
▸ MAPK10 P53779 4/20 0.48
▸ JAK2 O60674 1/20 0.44
▸ LRRK2 Q5S007 3/20 0.43
▸ TNKS O95271 1/20 0.41
▸ ROCK1 Q13464 1/20 0.41
▸ PARP1 P09874 1/20 0.41
▸ MAPK8 P45983 1/20 0.40
▸ PIK3CA P42336 1/20 0.40
▸ FGFR1 P11362 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ BTK Q06187 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10194768 0.85 FLT3 (0.55) FLT3MAPK10JAK2LRRK2ROCK1
SCHEMBL10194888 0.82 MAPK10 (0.43) FLT3MAPK10LRRK2PARP1MAPK8
SCHEMBL10194757 0.79 JAK2 (0.49) FLT3MAPK10JAK2LRRK2MAPK8
SCHEMBL10194762 0.79 ABL1 (0.45) FLT3MAPK10JAK2LRRK2PIK3CA
SCHEMBL10194924 0.77 JAK2 (0.52) FLT3MAPK10JAK2LRRK2PIK3CA
SCHEMBL10196821 0.77 JAK2 (0.46) FLT3MAPK10JAK2LRRK2PIK3CA
SCHEMBL10194693 0.77 LRRK2 (0.46) FLT3MAPK10LRRK2MAPK8FGFR1
SCHEMBL9959110 0.77 GRM4 (0.44) FLT3MAPK10JAK2LRRK2PIK3CA
SCHEMBL10194950 0.77 MAPK10 (0.44) FLT3MAPK10LRRK2MAPK8PIK3CA
SCHEMBL10194755 0.76 SMN1; SMN2 (0.44) FLT3MAPK10JAK2LRRK2PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2655357-B1 INDAZOLYL TRIAZOLE DERIVATIVES AS IRAK INHIBITORS MERCK SERONO SA (CH) 2016-06-22 — — EP disclosed
EP-2655357-B1 INDAZOLYL TRIAZOLE DERIVATIVES AS IRAK INHIBITORS MERCK SERONO SA (CH) 2016-06-22 — — EP disclosed
US-9073892-B2 Indazolyl triazol derivatives MERCK SERONO S.A. (CH) 2015-07-07 — — US disclosed
US-9073892-B2 Indazolyl triazol derivatives MERCK SERONO S.A. (CH) 2015-07-07 — — US disclosed
US-9073892-B2 Indazolyl triazol derivatives MERCK SERONO S.A. (CH) 2015-07-07 — — US disclosed
US-20130274241-A1 INDAZOLYL TRIAZOL DERIVATIVES MERCK SERONO S.A. - INTELLECTUAL PROPERTY (CH) 2013-10-17 — — US disclosed
US-20130274241-A1 INDAZOLYL TRIAZOL DERIVATIVES MERCK SERONO S.A. - INTELLECTUAL PROPERTY (CH) 2013-10-17 — — US disclosed
US-20130274241-A1 INDAZOLYL TRIAZOL DERIVATIVES MERCK SERONO S.A. - INTELLECTUAL PROPERTY (CH) 2013-10-17 — — US disclosed
WO-2012084704-A1 INDAZOLYL TRIAZOLE DERIVATIVES AS IRAK INHIBITORS MERCK SERONO S.A. (CH) 2012-06-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130274241-A1 INDAZOLYL TRIAZOL DERIVATIVES NFATC1, IL5, CD4 FLT3 282/4885MAPK10 1774/4885JAK2 66/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.